Researchers say they have developed a new, internally validated tool to distinguish between a low- and high-pretest probability of Cushing syndrome (CS) in patients. Details on the proposed “Cushing score” were published in Frontiers in Endocrinology.
To develop the score, a team of investigators performed a retrospective, multicenter case-control study that included 150 people with confirmed CS and 300 patients in which hypercortisolism was excluded. Patients were enrolled from 5 endocrinology centers in Italy. All patients were evaluated for suspected hypercortisolism according to current guidelines.
Bron: Endocrinoly Adivisor